TELA Bio (TELA) EBITDA Margin Growth (5y) (2023 - 2026)
TELA Bio (TELA) EBITDA Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,861.00 |
| Mar 31, 2026 | 6,846.00 |
| Dec 31, 2025 | 8,720.00 |
| Sep 30, 2025 | 9,266.00 |
| Jun 30, 2025 | 10,234.00 |
| Mar 31, 2025 | 11,788.00 |
| Dec 31, 2024 | 7,244.00 |
| Sep 30, 2024 | 4,765.00 |
| Jun 30, 2024 | 5,828.00 |
| Mar 31, 2024 | 12,762.00 |
| Dec 31, 2023 | 15,430.00 |
| Sep 30, 2023 | 4,647.00 |